These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 14896779)

  • 21. The effect of hydrogenated ergot alkaloids on elevated blood pressure levels.
    LABECKI TD; BRIGHT IB; GABLE GP; HAMILTON HN
    Miss Doct; 1953 Aug; 31(3):80-4. PubMed ID: 13072180
    [No Abstract]   [Full Text] [Related]  

  • 22. The hydrogenated ergot alkaloids (hydergine); a hypotensive agent.
    SCHULTZ FB
    Am Pract Dig Treat; 1953 May; 4(5):330-6. PubMed ID: 13050917
    [No Abstract]   [Full Text] [Related]  

  • 23. Experiences with hydergine in peripheral vascular disorders.
    CAITHAML W
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 278(4):396-408. PubMed ID: 13213192
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of combined hydrogenated ergot alkaloids (hydergine) in arterial hypertension with special reference to their action in central manifestations.
    TANDOWSKY RM
    Circulation; 1954 Jan; 9(1):48-56. PubMed ID: 13116375
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydrogenated ergot alkaloids (hydergine) in the treatment of geriatric postural dizziness.
    ORMA EJ
    Ann Med Intern Fenn; 1956; 45(1):39-44. PubMed ID: 13355071
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis of peripheral vascular disorders and their therapy with hydergin].
    OSTEN W; ZADEMACK HJ
    Arztl Wochensch; 1954 May; 9(19):437-41. PubMed ID: 13158230
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of hydergin on the experimental gangrene of the rat tail caused by ergotamine; correlations between genuine and hydrogenated ergot alkaloids].
    STUCKI P
    Arch Int Pharmacodyn Ther; 1952; 90(2-3):159-68. PubMed ID: 12977394
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical effects of dihydrogen derivatives of ergot in certain vascular conditions].
    JULY E; BABILLIOT J
    Sem Hop; 1954 Dec; 30(78):4369-71. PubMed ID: 13225837
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results with hydergin therapy of arteriosclerotic circulatory disorders].
    ZEMAN W; FINKEMEYER H
    Dtsch Med Wochenschr; 1951 Sep; 76(39):1207-9. PubMed ID: 14887473
    [No Abstract]   [Full Text] [Related]  

  • 30. [EFFECT OF HYDROGENATED ERGOT ALKALOIDS (HYDERGIN) ON THYROID FUNCTION].
    REVICZKY LA; SZANTO L; GRYNAEUS T
    Kiserl Orvostud; 1964 Jun; 16():323-30. PubMed ID: 14174079
    [No Abstract]   [Full Text] [Related]  

  • 31. [DRUG THERAPY OF OBLITERATIVE PROCESSES OF PERIPHERAL ARTERIOPATHIES].
    STRANO A
    Med Welt; 1965 Mar; 12():603-9. PubMed ID: 14293113
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of trophic ulcers of the soles of the feet in leprosy with certain hydrogenated ergot alkaloids.
    GOKHALE BB
    Dermatologica; 1956 Sep; 113(3):142-55. PubMed ID: 13375149
    [No Abstract]   [Full Text] [Related]  

  • 33. [Areflexia and peripheral vascular disease; therapeutic effects of hydergin].
    REWERTS G
    Med Klin; 1952 Apr; 47(14):437-9. PubMed ID: 14956553
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experiences with hydergine].
    STRAUSS LH
    Cardiologia (Basel); 1954; 25(1):1-36. PubMed ID: 13219632
    [No Abstract]   [Full Text] [Related]  

  • 35. [RESULTS OBTAINED WITH HYPACOM IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
    GARCIAZOZAYA R
    Cir Ginecol Urol; 1965; 19():27-38. PubMed ID: 14290989
    [No Abstract]   [Full Text] [Related]  

  • 36. [CLINICAL EVLUATION OF HYDERGINE IN GERIATRIC THERAPY].
    SOPRANA M; FRANZONI A
    Minerva Med; 1965 Jun; 56():2220-6. PubMed ID: 14341447
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of dehydrated ergot alkaloids (CCK 179, hydergin) in the treatment of disorders of peripheral circulation and in other sympathicotonic disorders; an analytic experiment].
    EICHLER O; HEINZEL J; LINDER F
    Klin Wochenschr; 1950 May; 28(17/18):298-304. PubMed ID: 15437776
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined vasodilator therapy in peripheral vascular diseases.
    POPKIN RJ
    J Am Geriatr Soc; 1960 Aug; 8():638-43. PubMed ID: 14434109
    [No Abstract]   [Full Text] [Related]  

  • 39. [DETERMINATION OF NON-HYDROGENATED AND HYDROGENATED ERGOT ALKALOIDS].
    GAWRYCH Z; WILCZYNSKA I
    Acta Pol Pharm; 1965; 22():1-12. PubMed ID: 14311546
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hydergine in the treatment of peripheral arteriopathies].
    KITAINIK E; SWIATLO MR
    Prensa Med Argent; 1959 Nov; 46():2758-61. PubMed ID: 14409490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.